Results 181 to 190 of about 26,368 (251)

Multi-center phase II study of nab-paclitaxel plus camrelizumab versus nab-paclitaxel alone as second-line treatment for advanced gastric cancer. [PDF]

Oncologist
Sun L, Gong Z, Wang L, Kuang L, Huang Q, Pei B, Yuan X, Qiu H.   +7 more
europepmc   +1 more source

Correction: Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis. [PDF]

Front Immunol
Hao W, Zhang J, Wang Y, Fang B, Jin S, Yuan J, Cai W.   +6 more
europepmc   +1 more source

Frailty, nutritional status, and inflammation as determinants of chemotherapy delivery and outcomes in pancreatic cancer patients receiving gemcitabine plus nab-paclitaxel. [PDF]

Front Oncol
Lee HS, Jeong CM, Lee JM, Kim TI, Kim SH, Jeon HJ, Choi HS, Kim ES, Keum B, Jeen YT.   +9 more
europepmc   +1 more source

Alpha-lipoic acid ameliorates nab-paclitaxel-induced peripheral neuropathy by inhibiting IL-17 signaling pathway. [PDF]

Front Immunol
Sun H, Cai Y, Li L, Xin X, Yan J, Huang T.   +5 more
europepmc   +1 more source

Unexpected Response to Nab-Paclitaxel in Poor Performance Status Lung Adenocarcinoma With a Unique 'Pan-Positive' Tumour Marker Profile: Case Report. [PDF]

Respirol Case Rep
Shimozono M, Kato T, Ohshima N, Kitani M, Maeda M, Nakamura S, Kusaka K, Shimada M, Tamura A.   +8 more
europepmc   +1 more source

Impact of Skeletal Muscle-related Parameters on Survival in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine plus Nab-paclitaxel as First-line Chemotherapy. [PDF]

J Cancer
Matsuo N, Yamaguchi T, Yukami H, Kodama H, Ikegami T, Kadono T, Kameisihi S, Okemoto D, Fakhrejahani E, Nishikawa H.   +9 more
europepmc   +1 more source

Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel

Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
We present a rare phenomenon of a soft tumor hanging on the woman's left upper arm that underwent necrosis from the distal aspect during chemotherapy for pancreatic cancer. The benign tumor, pedunculated lipofibroma, originally had normal color for 10 years and then became necrotic when she was treated with gemcitabine and nab-paclitaxel.
openaire  

Wöchentliche Gabe von nab-Paclitaxel besonders vorteilhaft [PDF]

best practice onkologie, 2011
openaire   +1 more source

NAB-paclitaxel and cisplatin versus gemcitabine and cisplatin as induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis. [PDF]

Ther Adv Med Oncol
Wang Q, Wang Z, Yang Q, Duan X, Peng L, You R, Liu Y, Xia T, Chen M, Huang P.   +9 more
europepmc   +1 more source

Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer. [PDF]

BMC Cancer
Easty D, McDermott R, Murphy AG, Grogan L, Morris PG, Breathnach OS, Egan K, Toomey S, Horgan A, Power D, Osman N, Parker I, Donachie V, Shevlin A, Barrett A, Nolan M, Marron J, Farr CJ, Hennessy BT.   +18 more
europepmc   +1 more source